Module 5: Tumours & Inflammatory Disease of the Spine
ChairmanProf. Bernhard Meyer
Lead ReviewerProf. Ciaran Bolger
Register Now!Follow the below link and start your course registration! esociety.netkey.at/eurospine/myeducation/
>> access to MyEducation
Please note that, if you already are an EUROSPINE member and wish to take advantage of the EUROSPINE member discount when registering for the module, you must ensure you have settled your 2018 membership fee before starting your course registration. This can be done through your MyUserArea >> membership.
Module 5 Learning Outcomes
The delegates should be able to assess the patient history and physical examination findings in relation to decision making; analyze the use of appropriate diagnostic tools; discuss the importance of using a broad base of evidence in decision making. Finally, they should be able to discuss prevention, identification and management of complications, familiarizing themselves with the outcome assessment tools and critical analysis of treatment results.
Session 1: Vertebral OsteomyletisThe origin of spinal infections will be discussed in detail, distinguishing primary and secondary infections. The delegates should be able to understand the pathological process of bacterial seeding and soiling as well as the strict protocols of the management, including diagnostic and therapeutic modalities.
Session 2: Rheumatic DiseasesThe delegates will be informed about the special problems of rheumatic disease like Rheumatoid Arthritis and Bechterews to the cervical spine and special surgical treatment options and considerations. Special focus will be developed on the cranio-cervical junction and possible surgical solution.
Session 3: Metabolic Bone DiseasesThey will learn the scale of the metabolic diseases, the differential diagnostics, diseases, symptoms and radiological and laboratory signs relating these pathological conditions. Therapeutic possibilities have to be addressed to the audience giving a wide description of the pathologies and recent therapeutic modalities.
Session 4 & Session 5: Primary Tumors & MetastasesThe delegates receive a comprehensive description of benign and malignant spine tumors. The characteristics of the intradural and spinal cord tumors are discussed, introducing the radiological appearance, clinical symptoms and methods of treatment like radiosurgery, open surgery and their functional and oncological outcomes. The delegates receive the basic knowledge about the spreading, seeding and soiling of the tumor cells in the vertebral structures. The epidemiology, symptomatology and diagnostic algorithms will be discussed in detail. As a result of this section, delegates will learn the different therapeutic algorithms and gold standard surgeries for spinal metastasis including postoperative care.
Session 6: Cad Labs